Table of Contents
Henry Ford Health and Michigan State University Health Sciences made the first investments from the Henry Ford MSU Innovation Fund, backing early-stage companies LightHearted AI and M3D.
What LightHearted AI Brings to the Henry Ford MSU Innovation Fund Portfolio
The organizations announced the deals in a July 30 news release shared with Becker’s. LightHearted AI is developing LightScope, a non-invasive tool that uses visible light to capture heart sound data and detect heart valve disease in under 10 seconds. The fund’s investment will support clinical validation as LightHearted AI seeks regulatory approval.
Why Speed and Non-Invasiveness Matter for This Diagnostic Tool
A screening tool capable of detecting heart valve disease in under 10 seconds using visible light rather than more invasive or time-intensive diagnostic methods could offer meaningful advantages for point-of-care screening, particularly in settings where rapid, low-burden cardiac assessment is valuable.
What M3D Contributes to This Innovation Fund’s First Investments
M3D is building radiation imaging technology that lets clinicians identify, localize and visualize radiation sources in real time, with applications in radiation safety and treatment accuracy. This real-time localization capability could prove valuable both for protecting clinical staff from unnecessary radiation exposure and for improving the precision of radiation-based treatments.
Two Distinct but Complementary Technology Areas
Together, these two investments span both diagnostic cardiac screening and radiation safety and treatment technology, reflecting the fund’s stated focus on precision medicine, digital health, medical devices, and related healthcare innovation areas rather than concentrating on a single technology category.
The Structure Behind the Henry Ford MSU Innovation Fund
The Innovation Fund launched in 2025 with a $10 million commitment from Henry Ford Health, Michigan State University and the MSU Research Foundation. It targets pre-seed through Series A companies in precision medicine, digital health, AI, medical devices and remote monitoring, and plans to invest about $2 million annually over five years.
A Deliberate, Multi-Year Investment Pace
This measured pace of roughly $2 million annually over five years suggests the fund is designed for sustained, long-term support of early-stage healthcare companies rather than a single large capital deployment, allowing it to potentially back multiple additional startups in future years.
The Path to These First Henry Ford MSU Innovation Fund Deals
The two deals are the fund’s first since it began evaluating applications, following a rollout that included an accelerator phase and legal work to establish the venture vehicle itself. This groundwork period, spanning both programmatic accelerator support and the legal formation of the investment vehicle, suggests the fund prioritized building a structured evaluation process before deploying its first capital.
Why This Milestone Matters
Reaching these first two investments marks a significant transition point for the fund, from organizational setup to active capital deployment, and may signal the pace at which additional pre-seed through Series A companies can expect the fund to evaluate and back new deals going forward.
What This Henry Ford MSU Innovation Fund Milestone Means Going Forward
With LightHearted AI and M3D now serving as the fund’s first backed companies, this investment offers an early signal of the kinds of precision medicine and medical device technologies the Henry Ford Health and Michigan State University partnership intends to prioritize. Given the fund’s five-year investment horizon and $10 million total commitment, these two deals likely represent just the beginning of a broader portfolio the fund plans to build across digital health, AI, and remote monitoring categories.
What to Watch Going Forward
As LightHearted AI pursues regulatory approval for its LightScope cardiac screening tool and M3D continues developing its radiation imaging technology, industry observers will likely watch how quickly the Henry Ford MSU Innovation Fund deploys its remaining capital toward additional pre-seed and Series A healthcare startups. Given the fund’s stated five-year timeline and focus areas spanning precision medicine, digital health, AI, medical devices, and remote monitoring, these first two investments may offer a useful template for the types of companies the fund will continue to prioritize going forward.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
